九州大学 研究者情報
研究者情報 (研究者の方へ)入力に際してお困りですか?
基本情報 研究活動 教育活動 社会活動 病院臨床活動
﨑村 正太郎(さきむら しようたろう) データ更新日:2024.04.12



主な研究テーマ
体外式連続心拍出量測定用センサーの違いによる術中低血圧発生頻度への影響
キーワード:体外式連続心拍出量測定用センサー、術中低血圧
2023.01.
医療機器の違いによるヘモグロビン濃度測定値の比較検討
キーワード:ヘモグロビン濃度、ポイントオブケア機器
2023.06.
周術期における麻酔薬による免疫機能変化に関する研究
キーワード:癌、転移再発、免疫、周術期
2019.04.
大腸癌の転移に関わる宿主側、腫瘍側因子の同定
キーワード:大腸癌、転移
2013.04~2017.03.
血中遊離循環DNAを用いた大腸癌の再発予測
キーワード:大腸癌、再発、血中遊離循環DNA
2013.04~2017.03.
従事しているプロジェクト研究
安定した循環動態が得られる 輸液量自動調節ソフトウェアの探索的臨床試験
2023.01~2024.03, 代表者:松木 悠佳, 福井大学医学部附属病院 麻酔科蘇生科, 福井大学医学部附属病院 麻酔科蘇生科
循環動態安定化のために必要となる輸液量を自動的に投与調節するソフトウェアの 有効性と安全性を評価する。.
非心臓手術後の心筋傷害の発生状況の調査
2024.01, 代表者:山浦健, 九州大学大学院医学研究院 麻酔・蘇生学分野, 九州大学大学院医学研究院麻酔・蘇生学分野
九州大学病院 麻酔科蘇生科
九州大学病院 手術部
九州大学病院 検査部
周術期の採血で心筋傷害のマーカーを測定することによって、手術後に発生する無症候性の心筋傷害の発生状況を解明する。.
研究業績
主要著書
主要原著論文
1. Shotaro Sakimura 1 2 , Satoshi Nagayama 3 , Mitsuko Fukunaga 1 , Qingjiang Hu 1 , Akihiro Kitagawa 1 , Yuta Kobayashi 1 , Takanori Hasegawa 4 , Miwa Noda 1 , Yuta Kouyama 1 , Dai Shimizu 1 , Tomoko Saito 1 , Atsushi Niida 5 , Yusuke Tsuruda 1 , Hajime Otsu 1 , Yoshihiro Matsumoto 1 , Hiroki Uchida 1 , Takaaki Masuda 1 , Keishi Sugimachi 1 , Shin Sasaki 6 , Kazutaka Yamada 7 , Kazuki Takahashi 8 , Hideki Innan 8 , Yutaka Suzuki 9 , Hiromi Nakamura 10 , Yasushi Totoki 10 , Shinichi Mizuno 11 , Masanobu Ohshima 12 , Tatsuhiro Shibata 10 13 , Koshi Mimori 1, Impaired tumor immune response in metastatic tumors is a selective pressure for neutral evolution in CRC cases, PLoS Genet., 10.1371/journal.pgen.1009113., 17, 1, e1009113, 2021.01, A Darwinian evolutionary shift occurs early in the neutral evolution of advanced colorectal carcinoma (CRC), and copy number aberrations (CNA) are essential in the transition from adenoma to carcinoma. In light of this primary evolution, we investigated the evolutionary principles of the genome that foster postoperative recurrence of CRC. CNA and neoantigens (NAG) were compared between early primary tumors with recurrence (CRCR) and early primary tumors without recurrence (precancerous and early; PCRC). We compared CNA, single nucleotide variance (SNV), RNA sequences, and T-cell receptor (TCR) repertoire between 9 primary and 10 metastatic sites from 10 CRCR cases. We found that NAG in primary sites were fewer in CRCR than in PCRC, while the arm level CNA were significantly higher in primary sites in CRCR than in PCRC. Further, a comparison of genomic aberrations of primary and metastatic conditions revealed no significant differences in CNA. The driver mutations in recurrence were the trunk of the evolutionary phylogenic tree from primary sites to recurrence sites. Notably, PD-1 and TIM3, T cell exhaustion-related molecules of the tumor immune response, were abundantly expressed in metastatic sites compared to primary sites along with the increased number of CD8 expressing cells. The postoperative recurrence-free survival period was only significantly associated with the NAG levels and TCR repertoire diversity in metastatic sites. Therefore, CNA with diminished NAG and diverse TCR repertoire in pre-metastatic sites may determine postoperative recurrence of CRC..
2. Shotaro Sakimura 1 2 , Keishi Sugimachi 1 , Junji Kurashige 1 , Masami Ueda 1 , Hidenari Hirata 1 , Sho Nambara 1 , Hisateru Komatsu 1 , Tomoko Saito 1 , Yuki Takano 1 , Ryutaro Uchi 1 , Etsuko Sakimura 1 , Yoshiaki Shinden 1 , Tomohiro Iguchi 1 , Hidetoshi Eguchi 1 , Yugo Oba 2 , Sumio Hoka 2 , Koshi Mimori 3, The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer, Ann Surg Oncol., 10.1245/s10434-015-4418-2., Suppl 3, 1436-1443, 2015.12, Background: MicroRNAs have roles in the regulation of the epithelial-mesenchymal transition (EMT). Findings have shown that miR-506 inhibits the expression of SNAI2 and that low expression of miR-506 is associated with poor prognoses in ovarian and breast cancers. This study investigated the role of miR-506 in survival and the EMT in patients with gastric cancer.

Methods: In this study, miR-506 and SNAI2 mRNA levels were measured in 141 cases of gastric cancer by quantitative reverse transcription polymerase chain reaction, and the protein expressions of SNAI2 and E-cadherin in 39 cases were validated by immunohistochemical analysis. Next, the associations between their expression levels and clinicopathologic factors were evaluated. In addition, cell proliferation, migration, and luciferase activity of the 3' untranslated region (UTR) of SNAI2 were analyzed using pre-miR-506 precursor in two human gastric cancer cell lines.

Results: Low expression of miR-506 was significantly correlated with poor overall survival in both the univariate analysis (P = 0.016) and the multivariate analysis (P